Lagarde AE - Search Results

1

Participation rates of Ashkenazi Jews in a colon cancer community-based screening/prevention study.

Cappelli M, Hunter AG, Stern H, Humphreys L, Van Houten L, O'Rourke K, Viertelhausen S, Perras H, Lagarde AE. Cappelli M, et al. Among authors: lagarde ae. Clin Genet. 2002 Feb;61(2):104-14. doi: 10.1034/j.1399-0004.2002.610205.x. Clin Genet. 2002. PMID: 11940085

2

APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.

Stern HS, Viertelhausen S, Hunter AG, O'Rourke K, Cappelli M, Perras H, Serfas K, Blumenthall A, Dewar D, Baumann E, Lagarde AE. Stern HS, et al. Among authors: lagarde ae. Gastroenterology. 2001 Feb;120(2):392-400. doi: 10.1053/gast.2001.21170. Gastroenterology. 2001. PMID: 11159880

3

Genetics of hereditary colon cancer: a model for prevention.

Stern H, Lagarde A. Stern H, et al. Can J Surg. 1998 Oct;41(5):345-50. Can J Surg. 1998. PMID: 9793501 Free PMC article.

4

Genetic pre-disposition to colorectal cancer: Initiation of a prospective study in Eastern Ontario.

Lagarde AE, Stern HS. Lagarde AE, et al. Int J Cancer. 1996 Feb 20;69(1):68-70. doi: 10.1002/(SICI)1097-0215(19960220)69:1<68::AID-IJC18>3.0.CO;2-G. Int J Cancer. 1996. PMID: 8600067

5

Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation.

Gallinger S, Aronson M, Shayan K, Ratcliffe EM, Gerstle JT, Parkin PC, Rothenmund H, Croitoru M, Baumann E, Durie PR, Weksberg R, Pollett A, Riddell RH, Ngan BY, Cutz E, Lagarde AE, Chan HS. Gallinger S, et al. Among authors: lagarde ae. Gastroenterology. 2004 Feb;126(2):576-85. doi: 10.1053/j.gastro.2003.11.008. Gastroenterology. 2004. PMID: 14762794

6

Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.

Mantha AJ, Hanson JE, Goss G, Lagarde AE, Lorimer IA, Dimitroulakos J. Mantha AJ, et al. Among authors: lagarde ae. Clin Cancer Res. 2005 Mar 15;11(6):2398-407. doi: 10.1158/1078-0432.CCR-04-1951. Clin Cancer Res. 2005. PMID: 15788691

7

Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations.

Waghorne C, Thomas M, Lagarde A, Kerbel RS, Breitman ML. Waghorne C, et al. Cancer Res. 1988 Nov 1;48(21):6109-14. Cancer Res. 1988. PMID: 3167857

8

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA. Tsao MS, et al. N Engl J Med. 2005 Jul 14;353(2):133-44. doi: 10.1056/NEJMoa050736. N Engl J Med. 2005. PMID: 16014883 Free article. Clinical Trial.

9

Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications.

Kerbel RS, Waghorne C, Korczak B, Lagarde A, Breitman ML. Kerbel RS, et al. Cancer Surv. 1988;7(4):597-629. Cancer Surv. 1988. PMID: 3072068 Review.

10

Genotypic and phenotypic evolution of a murine tumor during its progression in vivo toward metastasis.

Lagarde AE, Donaghue TP, Dennis JW, Kerbel RS. Lagarde AE, et al. J Natl Cancer Inst. 1983 Jul;71(1):183-91. J Natl Cancer Inst. 1983. PMID: 6575202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters